The Infectious Diseases Clinical Research Consortium (IDCRC) and Vaccine and Treatment Evaluation Units (VTEUs) work in tandem with the National Institute of Allergy and Infectious Diseases (NIAID) as a coordinated national and global network of scientific experts working to develop and test vaccines and other therapies to combat infectious diseases.


The IDCRC works through a flexible, sustaining structure to advance new countermeasures and approaches to product development, implement efficient clinical study/trial designs, and support exceptional career development and mentoring of future leaders in infectious diseases clinical research. The consortium's collective experience and access to diverse populations give it the ability to evaluate new vaccines and therapies for infectious diseases.

IDCRC Active & Completed Studies

IDCRC study explores challenges faced by early-stage faculty in Infectious Diseases and how to address these issues

The coronavirus disease 2019 (COVID-19) pandemic and associated increase in family care responsibilities resulted in unsustainable personal and professional workloads for infectious diseases (ID) faculty on the front lines. By investing in systemic change to make the ID workforce more equitable, we can embody the shared ideals of diversity and inclusion and prepare for the next pandemic.

Read More
IDCRC mentees use personal experience in infectious diseases to reflect on how the pandemic posed specific challenges with regard to career and family

COVID-19 Prevention Network

The CoVPN was established by merging four existing NIAID-funded clinical trials networks: the HIV Vaccine Trials Network; the HIV Prevention Trials Network; the Infectious Diseases Clinical Research Consortium; and the AIDS Clinical Trials Group.

More about the CoVPN
COVID-19 Prevention Network launches two research studies evaluating monoclonal antibodies

IDCRC Sites Across the Nation

IDCRC Leadership Group

Emory University School of Medicine

University of Maryland Baltimore

Baylor College of Medicine

Cincinnati Children’s Hospital Medical Center

FHI 360

Fred Hutch

University of Alabama School of Medicine

Johns Hopkins School of Medicine

Vanderbilt University Medical Center

University of Washington

IDCRC Vaccine & Treatment Evaluation Units (VTEUs)

IDCRC Concept Quick Stats

ICP Status

  • Approved: 46
  • Administratively Not Supported: 23
  • Revise & Resubmit: 5
  • Withdrawn: 12
  • Liaisons: 0
  • EWGs: 2
  • Not Approved: 43
  • EMT: 1
  • Other: 8

EWG Assignment

  • COVID: 86
  • Respiratory: 15
  • STI: 12
  • Malaria/Topical Diseases: 8
  • Enteric Infections: 6
  • Emerging Infections: 7
  • Mpox: 6


  • Prioritization/Protocol Development: 12
  • IDCRC Concept Study Underway: 4
  • Moved forward through other processes: 4
  • Pending: 5
  • Not approved: 9
  • In Process: 3
  • Hold: 5
  • Withdrawn/Halted: 7
  • Note: Protocols Transitioned to IDCRC for Protocol Implementation: 5
  • Other studies in process not from IDCRC concepts (MOMI-VAX, Moderna Pediatric, Moderna Variant, Moderna Boost): 5

IDCRC Citation Statement

Please include the following citation in any publications resulting from direct or indirect IDCRC support:

"Supported by the Infectious Diseases Clinical Research Consortium through the National Institute for Allergy and Infectious Diseases of the National Institutes of Health, under award number UM1AI148684. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health."